BioCentury | Aug 24, 2015
Clinical News

Chrysalis BioTherapeutics preclinical data

...TP508 is a 23-amino acid synthetic peptide portion of the receptor-binding domain of human thrombin. Chrysalis BioTherapeutics Inc....
Items per page:
1 - 1 of 1
BioCentury | Aug 24, 2015
Clinical News

Chrysalis BioTherapeutics preclinical data

...TP508 is a 23-amino acid synthetic peptide portion of the receptor-binding domain of human thrombin. Chrysalis BioTherapeutics Inc....
Items per page:
1 - 1 of 1